The U.S. Food and Drug Administration on Friday approved Mekinist for use with another drug, Tafinlar, to treat advanced melanoma that is spreading or cannot be removed by surgery. Melanoma is the most deadly form of skin cancer, ...
The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...
Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma
The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine